252 related articles for article (PubMed ID: 24987859)
1. Epidemiology of coronary heart disease in patients with human immunodeficiency virus.
Triant VA
Rev Cardiovasc Med; 2014; 15 Suppl 1(0 1):S1-8. PubMed ID: 24987859
[TBL] [Abstract][Full Text] [Related]
2. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus.
Beltrán LM; Rubio-Navarro A; Amaro-Villalobos JM; Egido J; García-Puig J; Moreno JA
Vasc Health Risk Manag; 2015; 11():35-48. PubMed ID: 25609975
[TBL] [Abstract][Full Text] [Related]
3. HIV infection and coronary heart disease: an intersection of epidemics.
Triant VA
J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S355-61. PubMed ID: 22577208
[TBL] [Abstract][Full Text] [Related]
4. Impact of antiretroviral medications on fasting lipid parameters.
Guaraldi G; Santoro A; Stentarelli C; Luzi K
Rev Cardiovasc Med; 2014; 15 Suppl 1():S30-7. PubMed ID: 24987861
[TBL] [Abstract][Full Text] [Related]
5. Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.
Gresele P; Falcinelli E; Momi S; Francisci D; Baldelli F
Rev Cardiovasc Med; 2014; 15 Suppl 1():S9-20. PubMed ID: 24987863
[TBL] [Abstract][Full Text] [Related]
6. Does antiretroviral therapy increase or decrease the risk of cardiovascular disease?
Fichtenbaum CJ
Curr HIV/AIDS Rep; 2010 May; 7(2):92-8. PubMed ID: 20425563
[TBL] [Abstract][Full Text] [Related]
7. Risk of coronary heart disease in patients with HIV infection.
Zanni MV; Schouten J; Grinspoon SK; Reiss P
Nat Rev Cardiol; 2014 Dec; 11(12):728-41. PubMed ID: 25331088
[TBL] [Abstract][Full Text] [Related]
8. HIV infection and coronary heart disease: mechanisms and management.
Hsue PY; Waters DD
Nat Rev Cardiol; 2019 Dec; 16(12):745-759. PubMed ID: 31182833
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries.
Lang S; Boccara F; Mary-Krause M; Cohen A
Arch Cardiovasc Dis; 2015 Mar; 108(3):206-15. PubMed ID: 25725995
[TBL] [Abstract][Full Text] [Related]
10. ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research.
Gamble-George JC; Longenecker CT; Webel AR; Au DH; Brown AF; Bosworth H; Crothers K; Cunningham WE; Fiscella KA; Hamilton AB; Helfrich CD; Ladapo JA; Luque A; Tobin JN; Wyatt GE;
Prog Cardiovasc Dis; 2020; 63(2):79-91. PubMed ID: 32199901
[TBL] [Abstract][Full Text] [Related]
11. Impact of nucleoside reverse transcriptase inhibitors on coronary heart disease.
Mallon PW
Rev Cardiovasc Med; 2014; 15 Suppl 1():S21-9. PubMed ID: 24987860
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
13. HIV-related cardiovascular disease: any role for high-density lipoproteins?
Hudson P; Woudberg NJ; Kamau F; Strijdom H; Frias MA; Lecour S
Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1221-H1226. PubMed ID: 33006917
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.
Pinto DSM; da Silva MJLV
Curr Cardiol Rev; 2018 Mar; 14(1):25-41. PubMed ID: 29189172
[TBL] [Abstract][Full Text] [Related]
15. Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.
Freeman ML; Lederman MM; Gianella S
Curr HIV/AIDS Rep; 2016 Feb; 13(1):10-9. PubMed ID: 26810437
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, pathophysiology, and prevention of heart failure in people with HIV.
Sinha A; Feinstein M
Prog Cardiovasc Dis; 2020; 63(2):134-141. PubMed ID: 31987806
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk and dyslipidemia management in HIV-infected patients.
Stein JH
Top Antivir Med; 2012; 20(4):129-33; quiz 123-4. PubMed ID: 23154252
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and management of cardiovascular disease in patients with HIV.
Nou E; Lo J; Hadigan C; Grinspoon SK
Lancet Diabetes Endocrinol; 2016 Jul; 4(7):598-610. PubMed ID: 26873066
[TBL] [Abstract][Full Text] [Related]
19. Elevated Eosinophils as a Feature of Inflammation Associated With Hypertension in Virally Suppressed People Living With HIV.
Masenga SK; Elijovich F; Hamooya BM; Nzala S; Kwenda G; Heimburger DC; Mutale W; Munsaka SM; Zhao S; Koethe JR; Kirabo A
J Am Heart Assoc; 2020 Feb; 9(4):e011450. PubMed ID: 32064996
[TBL] [Abstract][Full Text] [Related]
20. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy.
Haser GC; Sumpio B
J Vasc Surg; 2017 Mar; 65(3):849-859. PubMed ID: 26994951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
